Executive Director, Translational Medicine @ (November 2019 - May 2021)
Senior Principal Investigator, Translational Development @ (November 2011 - November 2016)
Director, Translational Development @ (June 2009 - December 2011)
Director, Drug Discovery @ (November 2006 - June 2009)
Associate Director, Drug Discovery @ (September 2003 - November 2006)
Group Leader, Immunotherapeutics @ (October 2001 - September 2003)
Senior Research Scientist, Immunotherapeutics @ (January 2001 - October 2001)
Research Scientist, Immunotherapeutics @ (April 1999 - January 2001)
Executive Director, Translational Development @ (November 2016 - November 2019)
Post Doctoral Research Fellow @ R. W. Johnson Pharmaceutical Research Institute (November 1996 - April 1999)
Peter Schafer Education
Northwestern University
PhD (Biochemistry, Molecular Biology and Cell Biology)
1991-1996
University of Chicago
B.S. (Biological Chemistry)
1987-1991
Peter Schafer Skills
Oncology
Immunology
Drug Discovery
Drug Development
Translational Medicine
Assay Development
Clinical Development
Biomarkers
Pharmacology
Hematology
Cell
Inflammation
In Vivo
In Vitro
Cell Biology
Biotechnology
Medicine
Microsoft Excel
Customer Service
Sales
Microsoft Office
Research
Peter Schafer Summary
Peter Schafer, based in Princeton, NJ, US, is currently a Chair, PROLIFIC Prognostic Lung Fibrosis Consortium at Pulmonary Fibrosis Foundation. Peter Schafer brings experience from previous roles at Bristol Myers Squibb, Bristol-Myers Squibb, Celgene Corporation and Celgene. Peter Schafer holds a 1991 - 1996 PhD in Biochemistry, Molecular Biology and Cell Biology @ Northwestern University. With a robust skill set that includes Oncology, Immunology, Drug Discovery, Drug Development, Translational Medicine and more. Peter Schafer has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Peter Schafer?
Find contact details for 700 million professionals.